Eledon Pharmaceuticals, Inc.
ELDN· Nasdaq
Released Mar 24, 2022, after the close
10-K filed Mar 24, 2022, 83 days after period end · 0001564590-22-011698
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$8.81M | -$5.90M | -$4.14M | -$4.57M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2021 · filed Mar 24, 2022 · 83 d after period end
+9.6% from the close of Mar 22, 2022 to the close of Mar 29, 2022, the first after the release.